Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.91 |
| ▸ | FAAH | O00519 | 1/20 | 0.91 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.91 |
| ▸ | CNR2 | P34972 | 1/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30306296 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL6259736 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL14106445 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL14864036 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| Linoleoylethanolamide SCHEMBL5145794 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL5412597 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL14106447 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL17097089 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| Linoleoylethanolamide SCHEMBL13110450 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL1334847 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695192-A2 | ANALGESIC COMPOUNDS COMPRISING CHARGED PARTICLES AND METHOD OF MANUFACTURE THEREOF | University of Connecticut (US) | 2026-02-18 | — | — | EP | claimed |
| US-20250339517-A1 | LIPID NANOCARRIER VACCINE | MELBOURNE INST TECH (AU) | 2025-11-06 | — | — | US | claimed |
| EP-4637690-A1 | OIL-CONTINUOUS COSMETIC COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-10-29 | — | — | EP | claimed |
| EP-4531812-A1 | LIPID NANOCARRIER VACCINE | Royal Melbourne Institute of Technology (AU) | 2025-04-09 | — | — | EP | claimed |
| WO-2025059525-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE SOLUBILITY OF CANNABINOIDS AND ENDOCANNABINOIDS | HYTHLAYN INC. (US) | 2025-03-20 | — | — | WO | claimed |
| CN-115697290-B | Cosmetic compositions with enhanced color stability for retinoic acid precursors | 联合利华知识产权控股有限公司 | 2025-02-25 | — | — | CN | claimed |
| WO-2024216279-A2 | ANALGESIC COMPOUNDS COMPRISING CHARGED PARTICLES AND METHOD OF MANUFACTURE THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2024-10-17 | — | — | WO | claimed |
| WO-2024132346-A1 | OIL-CONTINUOUS COSMETIC COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-06-27 | — | — | WO | claimed |
| US-20230404921-A1 | LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE | ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY (AU) | 2023-12-21 | — | — | US | claimed |
| EP-4094757-B1 | COMPOSITION OF ACYLETHANOLAMIDES FROM OLIVE OIL FATTY ACIDS | EPITECH GROUP S P A (IT) | 2023-12-20 | — | — | EP | claimed |
| US-6765024-B1 | Alkanolamide surfactant emulsions and process therefor | MCINTYRE GROUP, LTD. | 2004-07-20 | — | — | US | claimed |
| US-20040127572-A1 | Functional role for cannabinoids in autonomic stability during sleep | CARLEY DAVID W (US) | 2004-07-01 | — | — | US | claimed |
| EP-1372638-A1 | FUNCTIONAL ROLE FOR CANNABINOIDS IN AUTONOMIC STABILITY DURING SLEEP | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2004-01-02 | — | — | EP | claimed |
| WO-2002080903-A1 | FUNCTIONAL ROLE FOR CANNABINOIDS IN AUTONOMIC STABILITY DURING SLEEP | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2002-10-17 | — | — | WO | claimed |
| US-6440434-B1 | PETROSELINIC ACID OR DERIVATIVE; AND RETINOL, RETINOIC ACID OR RETINYL LINOLEATE; TOPICAL; SKIN AGING AND WRINKLE RESISTANCE; DERMATOLOGY | CONOPCO, INC. | 2002-08-27 | — | — | US | claimed |
| EP-1175197-A4 | ALKANOLAMIDE SURFACTANT EMULSIONS AND PROCESS THEREFOR | MCINTYRE GROUP LTD (US) | 2002-05-15 | — | — | EP | claimed |
| EP-1175197-A1 | ALKANOLAMIDE SURFACTANT EMULSIONS AND PROCESS THEREFOR | THE McINTYRE GROUP, LTD. (US) | 2002-01-30 | — | — | EP | claimed |
| WO-2000061086-A1 | ALKANOLAMIDE SURFACTANT EMULSIONS AND PROCESS THEREFOR | MCINTYRE GROUP, LTD. (US) | 2000-10-19 | — | — | WO | claimed |
| US-5716627-A | SKIN CONDITIONING | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1998-02-10 | — | — | US | claimed |
| US-5599548-A | REDUCING OR PREVENTING THE APPEARANCE OF WRINKLED OR AGED SKIN | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1997-02-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339517-A1 | LIPID NANOCARRIER VACCINE | CD47, LY96, TSG101 | CNR1 3259/4885ALDH1A1 4427/4885HPGD 2406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.